FDA approves new treatment for a rare genetic disorder, Fabry disease August 10, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.